Influence of neuroendocrine tumor cells on proliferation in prostatic carcinoma

Human Pathology

Volumn 36, Issue 5, 2005, Pages 562-570

  Grobholz, Rainer ^a   Griebe, Martin ^a   Sauer, Christian G ^a   Michel, Maurice S ^a   Trojan, Lutz ^a   Bleyl, Uwe ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Ki 67; Neuroendocrine tumor differentiation; PLK1; Proliferation; Prostatic carcinoma

Indexed keywords

KI 67 ANTIGEN; MESSENGER RNA; POLO LIKE KINASE 1; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER RELAPSE; CANCER SURVIVAL; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE MARKER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NEUROENDOCRINE TUMOR; PARACRINE SIGNALING; PROGNOSIS; PROSTATE CARCINOMA; PROSTATECTOMY; PROTEIN EXPRESSION; TUMOR CELL; TUMOR DIFFERENTIATION; TUMOR GROWTH; TUMOR LOCALIZATION; WESTERN BLOTTING;

BLOTTING, NORTHERN; BLOTTING, WESTERN; CARCINOMA, NEUROENDOCRINE; CELL CYCLE PROTEINS; CELL PROLIFERATION; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; PROGNOSIS; PROSTATIC NEOPLASMS; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 20144374569     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2005.02.019     Document Type: Article

References (38)

1. A. Jemal, A. Thomas, and T. Murray Cancer statistics CA Cancer J Clin 52 2002 23 47
2. P.A. di Sant'Agnese Neuroendocrine cells of the prostate and neuroendocrine differentiation in prostatic carcinoma: a review of morphologic aspects Urology 51 1998 121 124
3. P.A. Abrahamsson Neuroendocrine cells in tumour growth of the prostate Endocr Relat Cancer 6 1999 503 519
4. H. Bonkhoff, U. Stein, and K. Remberger Androgen receptor status in endocrine-paracrine cell types of the normal, hyperplastic, and neoplastic human prostate Virchows Arch A Pathol Anat Histopathol 423 1993 291 294
5. T. Burchardt, M. Burchardt, and M.W. Chen Transdifferentiation of prostate cancer cells to a neuroendocrine cell phenotype in vitro and in vivo J Urol 162 1999 1800 1805
6. T. Jiborn, A. Bjartell, and P.A. Abrahamsson Neuroendocrine differentiation in prostatic carcinoma during hormonal treatment Urology 51 1998 585 589
7. R. Grobholz, M.H. Bohrer, and M. Siegsmund Correlation between neovascularisation and neuroendocrine differentiation in prostatic carcinoma Pathol Res Pract 196 2000 277 284
8. P.A. di Sant'Agnese Neuroendocrine differentiation in prostatic carcinoma: an update on recent developments Ann Oncol 12 Suppl. 2 2001 S135 S140
9. H. Bonkhoff, N. Wernert, and G. Dhom Relation of endocrine-paracrine cells to cell proliferation in normal, hyperplastic, and neoplastic human prostate Prostate 19 1991 91 98
10. M. Woenckhaus, and M.H. Bohrer Beziehung zwischen neuroendokrin differenzierten und proliferationsaktiven Tumorkompartimenten im Prostatakarzinom Verh Dtsch Ges Pathol 81 1997 751
11. M. Griebe, T.M. Jaeger, and G. Wolf PLK in prostatic carcinoma: influence of neuroendocrine tumor cells on proliferation J Cancer Res Clin Oncol 127 Suppl. 1 2001 S41
12. M.A. Noordzij, W.M. van Weerden, and C.M. de Ridder Neuroendocrine differentiation in human prostatic tumor models Am J Pathol 149 1996 859 871
13. H. Bonkhoff Neuroendocrine cells in benign and malignant prostate tissue: morphogenesis, proliferation, and androgen receptor status Prostate Suppl. 8 1998 18 22
14. H. Bonkhoff, U. Stein, and K. Remberger Endocrine-paracrine cell types in the prostate and prostatic adenocarcinoma are postmitotic cells Hum Pathol 26 1995 167 170
15. R.M. Golsteyn, K.E. Mundt, and A.M. Fry Cell cycle regulation of the activity and subcellular localization of Plk1, a human protein kinase implicated in mitotic spindle function J Cell Biol 129 1995 1617 1628
16. M.M. Donaldson, A.A. Tavares, and I.M. Hagan The mitotic roles of Polo-like kinase J Cell Sci 114 2001 2357 2358
17. R. Hamanaka, M.R. Smith, and P.M. O'Connor Polo-like kinase is a cell cycle-regulated kinase activated during mitosis J Biol Chem 270 1995 21086 21091
18. G. Wolf, R. Elez, and A. Doermer Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer Oncogene 14 1997 543 549
19. R. Knecht, R. Elez, and M. Oechler Prognostic significance of polo-like kinase (PLK) expression in squamous cell carcinomas of the head and neck Cancer Res 59 1999 2794 2797
20. L. Kneisel, K. Strebhardt, and A. Bernd Expression of polo-like kinase (PLK1) in thin melanomas: a novel marker of metastatic disease J Cutan Pathol 29 2002 354 358
21. S. Aaltomaa, P. Lipponen, and S. Vesalainen Value of Ki-67 immunolabelling as a prognostic factor in prostate cancer Eur Urol 32 1997 410 415
22. L. Bubendorf, G. Sauter, and H. Moch Ki67 labelling index: an independent predictor of progression in prostate cancer treated by radical prostatectomy J Pathol 178 1996 437 441
23. W. Weichert, M. Schmidt, and V. Gekeler Polo-like kinase 1 is overexpressed in prostate cancer and linked to higher tumor grades Prostate 60 2004 240 245
24. L.D. True Surgical pathology examination of the prostate gland. Practice survey by American society of clinical pathologists Am J Clin Pathol 102 1994 572 579
25. D.F. Gleason Histologic grading of prostate cancer: a perspective Hum Pathol 23 1992 273 279
26. R. Grobholz, H. Zentgraf, and K.U. Köhrmann Bax, Bcl-2, Fas and Fas-L antigen expression in human seminoma: correlation with the apoptotic index APMIS 110 2002 724 732
27. U. Holtrich, G. Wolf, and A. Bräuninger Induction and down-regulation of PLK, a human serine/threonine kinase expressed in proliferating cells and tumors Proc Natl Acad Sci U S A 91 1994 1736 1740
28. P.A. di Sant'Agnese Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications Cancer 70 1992 254 268
29. M.E. Harper, G.E. Jones, and L. Goddard Vascular endothelial growth factor (VEGF) expression in prostatic tumours and its relationship to neuroendocrine cells Br J Cancer 74 1996 910 916
30. P.J. Hepburn, K. Griffiths, and M.E. Harper Angiogenic factors expressed by human prostatic cell lines: effect on endothelial cell growth in vitro Prostate 33 1997 123 132
31. M.T. Sheaff, J.E. Martin, and D.F. Badenoch beta hCG as a prognostic marker in adenocarcinoma of the prostate J Clin Pathol 49 1996 329 332
32. P.A. di Sant'Agnese Neuroendocrine differentiation in prostatic carcinoma: an update Prostate Suppl. 8 1998 74 79
33. D. Theodorescu, S.R. Broder, and J.C. Boyd Cathepsin D and chromogranin A as predictors of long term disease specific survival after radical prostatectomy for localized carcinoma of the prostate Cancer 80 1997 2109 2119
34. H. Ishimaru, Y. Kageyama, and T. Hayashi Expression of matrix metalloproteinase-9 and bombesin/gastrin-releasing peptide in human prostate cancers and their lymph node metastases Acta Oncol 41 2002 289 296
35. R. Knecht, C. Oberhauser, and K. Strebhardt PLK (polo-like kinase), a new prognostic marker for oropharyngeal carcinomas Int J Cancer 89 2000 535 536
36. N. Takai, T. Miyazaki, and K. Fujisawa Polo-like kinase (PLK) expression in endometrial carcinoma Cancer Lett 169 2001 41 49
37. G. Wolf, R. Hildenbrand, and C. Schwar Polo-like kinase: a novel marker of proliferation: correlation with estrogen-receptor expression in human breast cancer Pathol Res Pract 196 2000 753 759
38. M.E. Cox, P.D. Deeble, and S. Lakhani Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression Cancer Res 59 1999 3821 3830